Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Testicular Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Breast Neoplasms 1

Interventions

Carboplatin 8Cisplatin 7Etoposide 6Bleomycin 6sargramostim 3Radiotherapy 3Ifosfamide 3pegfilgrastim 2ixabepilone 2aldesleukin 2Trastuzumab 2Temozolomide 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Filgrastim 2veliparib 1tipifarnib 1lerisetron 1etoposide phosphate 1entinostat 1dehydroftorafur 1cytokine inducible SH2-containing protein 1alvocidib 1Vincristine 1Vinblastine 1Taxes 1Polymerase Chain Reaction 1PT-100 dipeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Testicular Neoplasms × Interleukin-1 × Clear all
NCT00001270 2008-03-04

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
85 enrolled
BreastGenitourinaryLymphoid

Breast Neoplasms, Lymphoma, Neoplasm Metastasis, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡